JENNIFER EASLEY: Open Payments
NPI 1972827251 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 28 payments from 13 companies in 2025. Trend: 2023 $452 · 2024 $463 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $195 |
| Lilly USA, LLC | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Abbott Laboratories | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Seqirus USA Inc | 1 | $31 |
| Exact Sciences Corporation | 1 | $20 |
Products named: Wegovy, Ozempic, JARDIANCE, Auvelity, CAPLYTA, AIRSUPRA, REXULTI, MOUNJARO.
Industry payments across TX — which companies pay providers there.
